Separating the contributions of SLC26A9 and CFTR to anion secretion in primary human bronchial epithelia
- 1 December 2021
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 321 (6) , L1147-L1160
Abstract
Aberrant anion secretion across the bronchial epithelium is associated with airway disease, most notably in cystic fibrosis. Although the cystic fibrosis transmembrane conductance regulator (CFTR) is recognized as the primary source of airway anion secretion, alternative anion transport mechanisms play a contributing role. An alternative anion transporter of growing interest is SLC26A9, a constitutively active chloride channel that has been shown to interact with CFTR and may also contribute to bicarbonate secretion. Interest in SLC26A9 has been fueled by genome-wide association studies that suggest it is a significant modifier of CF disease severity. Despite this growing evidence that SLC26A9 plays an important role in the airway, its presence and function in bronchial epithelia remain poorly understood, in part, because its activity is difficult to separate from the activity of CFTR. Here, we present results using primary human bronchial epithelia (HBE) from multiple patient sources to confirm that SLC26A9 mRNA is present in HBE and that its constitutive channel activity is unaffected by knockdown of CFTR. Furthermore, SLC26A9 and CFTR show differential responses to common inhibitors of anion secretion. Finally, we assess the impact of bicarbonate on the activity of SLC26A9 and CFTR. These results confirm that SLC26A9 is the primary source of constitutive anion secretion across HBE, and should inform future studies focused on activation of SLC26A9 as an alternative anion channel in CF. These results should provide a strong foundation to investigate how single-nucleotide polymorphisms in SLC26A9 modulate airway disease.Keywords
Funding Information
- Cystic Fibrosis Foundation (BERTRA12G0)
- Cystic Fibrosis Foundation (BERTRA17P0)
- Cystic Fibrosis Foundation (R883-15R0)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK068196)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (P30-DK072506)
This publication has 31 references indexed in Scilit:
- Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosisNature Genetics, 2012
- Cardiac ion channel current modulation by the CFTR inhibitor GlyH-101Biochemical and Biophysical Research Communications, 2011
- Acute Regulation of the Epithelial Sodium Channel in Airway Epithelia by Proteases and TraffickingAmerican Journal of Respiratory Cell and Molecular Biology, 2010
- On the mechanism of CFTR inhibition by a thiazolidinone derivativeJournal of General Physiology, 2010
- Diverse transport modes by the solute carrier 26 family of anion transportersThe Journal of Physiology, 2009
- Slc26a9—Anion Exchanger, Channel and Na+ TransporterThe Journal of Membrane Biology, 2009
- SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epitheliaJournal of General Physiology, 2009
- Chaperone displacement from mutant cystic fibrosis transmembrane conductance regulator restores its function in human airway epitheliaThe FASEB Journal, 2008
- SLC26A9 is a Cl− channel regulated by the WNK kinasesThe Journal of Physiology, 2007
- Slc26a6 regulates CFTR activity in vivo to determine pancreatic duct HCO3 − secretion: relevance to cystic fibrosisThe EMBO Journal, 2006